MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
159 hedge funds and large institutions have $2.96B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
+47
Holders Change %
+41.96%
% of All Funds
3.45%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
58
Increased
53
Reduced
37
Closed
11
Calls
$66.1M
Puts
$32.6M
Net Calls
+$33.5M
Net Calls Change
+$30.5M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$177M |
| 2 |
PA
Perceptive Advisors
New York
|
+$76.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$70.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$35.8M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$68.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$49.6M |
| 3 |
DM
Deerfield Management
New York
|
-$45.6M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$20.9M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$18.8M |
